Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest

Table 2 Characteristics of patients with severe vs. life-threatening disease receiving COVID-19 convalescent plasma at time of transfusion^a

	COVID-19 Classification
	Severe	Life-Threatening
	n = 16	n = 15	p^b
Female sex – no. (%)	7 (44)	3 (20)	0.252
BMI	37.3 ± 8.4	37.5 ± 12.6	0.964
Sequential Organ Failure Assessment (SOFA) Score	0 [1.5]	4 [2]	0.001
C-reactive protein – mg/dL	12.0 ± 9.8	19.5 ± 7.6	0.028
D-dimer – mcg/mL	1.86 ± 3.08	3.55 ± 4.96	0.271
Ferritin – ng/mL	1469 ± 1764	1594 ± 1018	0.821
In-Hospital Death – no. (%)	0	4 (27%)	0.037
Length of stay – days	9 [4]	21.5 [25.5]	0.012

^aPlus-minus values are means ± SD, values with brackets are medians [interquartile range]
^bFisher’s exact test, Student’s T-test, or Wilcoxon-Mann-Whitney test as appropriate

ISSN: 2396-832X